| Serial Number | 79231543 |
| Word Mark | BP 3B PHARMACEUTICALS |
| Filing Date | Wednesday, December 27, 2017 |
| Status | 739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Wednesday, June 18, 2025 |
| Registration Number | 5699890 |
| Registration Date | Tuesday, March 19, 2019 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 1, 2019 |
| Description of Mark | The mark consists of the wording "3B PHARMACEUTICALS" and to the left of the wording is a circle with connected stylized letters "BP" within. |
| Certificate of Correction for Registration | In the Statement Class 42, has been updated in accordance with the F-note dated 5/17/2021. |
| Pseudo Mark | BP THREE B PHARMACEUTICALS |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "PHARMACEUTICALS" |
| Goods and Services | Technological consultation and research in the field of chemical analysis; Analysis of industrial fluids; chemical analysis; biological research; research relating to biotechnology; research in the field of chemistry, biotechnology, pharmacy or pharmacology; research and development and research into new products for others, in particular new medicines or diagnostic preparations for others; research and development of drug candidates for medicines, in particular peptide medicines; research and development of chemical or biotechnological preparations for diagnostic preparations, in particular of chemical or biotechnological preparations for targeted molecular imaging; chemical, biotechnological or pharmacological surveys, in particular for research and development of drug candidates for medicines or research and development of biotechnological preparations for diagnostic preparations; research and development services for biotechnical manufacturing of medical or diagnostic products; in-vitro pharmacological analysis services for absorption, distribution, metabolism, and excretion of drug candidates * ; with the proviso that all the aforementioned services do not include biotechnological production of drug candidates or medicaments using (i) cell-based technologies and (ii) cell-free technologies in amounts larger than 10 mg * |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 14, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | 3B Pharmaceuticals GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Berlin 12489 DE |
| Party Name | 3B Pharmaceuticals GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Party Name | 3B Pharmaceuticals GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Thursday, May 10, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, May 11, 2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Monday, May 14, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 14, 2018 | ASSIGNED TO EXAMINER |
| Monday, May 14, 2018 | NON-FINAL ACTION WRITTEN |
| Tuesday, May 15, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, May 18, 2018 | APPLICATION FILING RECEIPT MAILED |
| Friday, May 18, 2018 | REFUSAL PROCESSED BY MPU |
| Friday, May 18, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, June 9, 2018 | REFUSAL PROCESSED BY IB |
| Monday, November 19, 2018 | ASSIGNED TO LIE |
| Monday, November 19, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 19, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 12, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 1, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 19, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, June 19, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, November 7, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 19, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 1, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, July 10, 2019 | FINAL DISPOSITION PROCESSED |
| Friday, July 26, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Saturday, May 15, 2021 | LIMITATION OF GOODS RECEIVED FROM IB |
| Thursday, May 20, 2021 | ASSIGNED TO PARALEGAL |
| Thursday, May 20, 2021 | CORRECTION UNDER SECTION 7 - PROCESSED |
| Thursday, May 20, 2021 | LIMITATION FROM THE IB EXAMINED AND ENTERED |
| Wednesday, July 10, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, May 18, 2022 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
| Thursday, January 20, 2022 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Tuesday, March 19, 2024 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Monday, March 10, 2025 | TEAS SECTION 71 & 15 RECEIVED |
| Wednesday, June 18, 2025 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Wednesday, June 18, 2025 | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. |
| Wednesday, June 18, 2025 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |